Concepedia

Ken Dower

KD

Statistics

Publications

25

Citations

2.3K

H-Index

23

Active since

1998

Affiliations

Pfizer (United States)(Current)

Howard Hughes Medical Institute

Brandeis University

Boston University

United States Army Medical Research Institute of Infectious Diseases

Ken Dower is an author at Pfizer (United States) specializing in life sciences, molecular biology, and gene expression.

ORCID

Publications per year

1998–2023

25

Publications

25

Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation

Thomas Fabre, Alex Barron, Stephen M. Christensen et al. · Science Immunology · 2023 · 302 citations

, , +17

Interactions between mRNA Export Commitment, 3′-End Quality Control, and Nuclear Degradation

Domenico Libri, Ken Dower, Jocelyne Boulay et al. · Molecular and Cellular Biology · 2002 · 248 citations

, , +17

Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation

Michael J. Primiano, Bruce A. Lefker, Michael Bowman et al. · The Journal of Immunology · 2016 · 178 citations

, , +17

Innate Immune Responses to TREM-1 Activation: Overlap, Divergence, and Positive and Negative Cross-Talk with Bacterial Lipopolysaccharide

Ken Dower, Debra Ellis, Kathryn A. Saraf et al. · The Journal of Immunology · 2008 · 177 citations

, , +17

Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay

J. Perry Hall, Amy Brault, Fabien Vincent et al. · PLoS ONE · 2017 · 162 citations · Full text

, , +17

1–5 of 25